drugset / Trial / NCT03398759
Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Emergence agitation is one of the common postoperative complications after functional endoscopic sinus surgery(FESS). The objective of present study is to explore the effectiveness of butorphanol in the alleviation of emergence agitation in patients undergoing Functional Endoscopic Sinus Surgery.
Timeline
- Start
- 2018-02-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Butorphanol | Other / unclassified | 20 ug/kg | Intravenous |
Indications
No indication recorded.